1. US rules out bailout for Silicon Valley Bank, auctions reportedly underway 2. Apple CEO Tim Cook backs AR/VR headset, likely to launch this year 3. Infosys’ Mohit Joshi joins Tech Mahindra as MD and CEO

Cipla receives EUA for oral antiviral drug to treat mild-to-moderate Covid

Spread the love

Cipla Limited announced on Tuesday that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir, an anti-viral drug to treat mild-to-moderate Covid-19.

Cipla plans to launch Molnupiravir under the brand name Cipmolnu. Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate Covid-19 at high risk of developing severe disease.

Earlier this year, Cipla entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply Molnupiravir in India and to over 100 low and middle-income countries (LMICs). The regulatory approval comes on the back of a five-month collaborative trial conducted by a consortium of companies.

Cipla will soon make Cipmolnu 200 mg capsules, which will be available at all leading pharmacies and Covid treatment centres across the country.

Claim Free Bets

The company has adequate manufacturing capacities and a solid distribution mechanism in place to ensure speedy access to this effective treatment pan India.

Molnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2. The drug is used for the treatment of non-hospitalised patients with Covid-19 globally.

Commenting on the launch, Umang Vohra (MD and Global CEO, Cipla Limited) said it was “yet another step in our endeavour to enable access to all treatments in Covid care”.

    THE FREE MEDIA

    THE FREE MEDIA

    All Posts

    Related Post

    View All

    Suu Kyi sentenced to 4 yrs in jail

    December 6th, 2021 | THE FREE MEDIA

    Spread the loveAung San Suu Kyi, the former de facto leader of Myanmar who was ousted during the February 1 military coup,...

    No booster necessary for Dutch teens, health council...

    February 7th, 2022 | Ankita Deshkar

    Spread the loveThe Dutch health council has decided that it is not necessary to offer booster vaccinations to teenagers be...

    From 22 December 2021 new entry rules for Netherlands

    December 21st, 2021 | Ankita Deshkar

    Spread the loveStarting on 22 December 2021 0:01 AM new rules will go into effect: travellers from outside the EU/Schengen...